Lynne H. Brum's most recent trade in Yield10 Bioscience Inc was a trade of 731 Common Stock done at an average price of $1.5 . Disclosure was reported to the exchange on Aug. 15, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Yield10 Bioscience Inc | Lynne H. Brum | VP Planning and Communications | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.50 per share. | 15 Aug 2024 | 731 | 5,867 (0%) | 0% | 1.5 | 1,097 | Common Stock |
| Yield10 Bioscience Inc | H. Lynne Brum | VP, Planning and Corporate Com | Grant, award, or other acquisition of securities at price $ 0.30 per share. | 15 Feb 2024 | 100,000 | 108,326 (6%) | 5% | 0.3 | 30,000 | Common Stock |
| Yield10 Bioscience Inc | Lynne H. Brum | VP Planning and Communications | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.59 per share. | 10 Feb 2023 | 1,029 | 8,323 (0%) | 0% | 3.6 | 3,694 | Common Stock |
| Yield10 Bioscience Inc | Lynne H. Brum | VP Planning and Communications | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2023 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Yield10 Bioscience Inc | Lynne H. Brum | VP Planning and Comms | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.68 per share. | 10 Aug 2022 | 864 | 9,352 (0%) | 0% | 2.7 | 2,316 | Common Stock |
| Yield10 Bioscience Inc | Lynne H. Brum | VP Planning and Comms | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.25 per share. | 01 Mar 2022 | 366 | 10,216 (0%) | 0% | 4.3 | 1,556 | Common Stock |
| Yield10 Bioscience Inc | Lynne H. Brum | VP Planning and Comms | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Yield10 Bioscience Inc | Lynne H. Brum | VP Planning and Comms | Grant, award, or other acquisition of securities at price $ 3.83 per share. | 10 Feb 2022 | 5,891 | 10,582 (0%) | 0% | 3.8 | 22,563 | Common Stock |
| Yield10 Bioscience Inc | Lynne H. Brum | VP Planning and Comms | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2021 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Yield10 Bioscience Inc | Lynne H. Brum | VP Planning and Comms | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.71 per share. | 01 Sep 2021 | 307 | 4,691 (0%) | 0% | 6.7 | 2,060 | Common Stock |
| Yield10 Bioscience Inc | Lynne H. Brum | VP Planning & Comms | Grant, award, or other acquisition of securities at price $ 16.03 per share. | 01 Mar 2021 | 2,092 | 4,998 (0%) | 0% | 16.0 | 33,535 | Common Stock |
| Yield10 Bioscience Inc | Lynne H. Brum | VP Planning & Comms | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.77 per share. | 11 Feb 2021 | 693 | 2,906 (0%) | 0% | 22.8 | 15,780 | Common Stock |
| Yield10 Bioscience Inc | Lynne H. Brum | VP Planning & Comms | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2021 | 11,500 | 11,500 | - | - | Stock Option (right to buy) | |
| Yield10 Bioscience Inc | Lynne H. Brum | VP Planning & Comms | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.55 per share. | 11 Aug 2020 | 587 | 3,599 (0%) | 0% | 6.6 | 3,845 | Common Stock |